Global Fertility Drug And Surgery Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Underlying Cause;

Male and Female.

By Drug;

Clomiphene Citrate, Letrozole, Serophene, Hormone Treatment, Gonadotrophins, Aromatase Inhibitors, Estrogen Receptor Modulators, Dopamine Agonists, Metformin Hydrochloride, and Others.

By Procedures;

Hysteroscopy, Laparoscopy and Robotic Laparoscopy, Laparotomy/Open Surgery, Egg Retrieval, Varicocelectomy, Vasectomy Reversal, and Sperm Retrieval.

By End User;

Fertility Clinics, Hospitals, Clinical Research Institutes, and Others.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa, and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn156226778 Published Date: January, 2025 Updated Date: February, 2025

Introduction

Global Fertility Drug And Surgery Market (USD Million), 2021 - 2031

In the year 2024, the Global Fertility Drug And Surgery Market was valued at USD 1,312.24 million. The size of this market is expected to increase to USD 2,507.16 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 9.7%.

The global fertility drug and surgery market plays a crucial role in addressing infertility issues worldwide, catering to a growing demographic seeking assistance in starting or expanding families. Fertility drugs, including hormonal treatments like clomiphene citrate and gonadotropins, are pivotal in stimulating ovulation and enhancing the chances of conception for women experiencing difficulties due to hormonal imbalances or irregularities. These medications are often the first line of treatment prescribed by fertility specialists and are continuously evolving with advancements in medical research and technology.

Surgical interventions also form a significant part of the fertility market, offering solutions for structural abnormalities that may hinder conception. Procedures such as laparoscopy and hysteroscopy are utilized to diagnose and treat conditions like endometriosis, uterine fibroids, or polyps that can affect fertility. These surgeries are minimally invasive, reducing recovery times and improving outcomes for patients seeking reproductive health enhancement.

The market for fertility drugs and surgeries is driven by increasing awareness and acceptance of fertility treatments, coupled with rising incidences of infertility due to factors such as delayed childbearing, lifestyle changes, and environmental influences. Advancements in assisted reproductive technologies (ART) further augment market growth, offering options like in vitro fertilization (IVF) and intrauterine insemination (IUI) to couples struggling with infertility.

The market also faces challenges such as regulatory complexities and ethical concerns surrounding assisted reproductive procedures. Despite these challenges, ongoing research and development continue to expand the scope of available treatments, aiming to improve success rates and ensure safer, more effective solutions for individuals and couples navigating the complexities of fertility issues. As the demand for fertility solutions continues to rise globally, the market for drugs and surgical interventions is poised for further expansion, driven by innovation and a growing emphasis on personalized reproductive healthcare.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Underlying Cause
    2. Market Snapshot, By Drug
    3. Market Snapshot, By Procedures
    4. Market Snapshot, By End User
    5. Market Snapshot, By Region
  4. Global Fertility Drug And Surgery Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing infertility rates globally
        2. Advancements in reproductive technologies
        3. Rising awareness about fertility treatments
        4. Growing trend of delayed pregnancies
      2. Restraints
        1. High costs of fertility treatments
        2. Ethical concerns surrounding reproductive technologies
        3. Limited accessibility to advanced treatments
        4. Side effects associated with fertility drugs
      3. Opportunities
        1. Emerging markets in developing countries
        2. Technological innovations in fertility treatments
        3. Rising investments in healthcare infrastructure
        4. Increasing acceptance of fertility solutions
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Fertility Drug And Surgery Market, By Underlying Cause, 2021 - 2031 (USD Million)
      1. Male
      2. Female
    2. Global Fertility Drug And Surgery Market, By Drug, 2021 - 2031 (USD Million)
      1. Clomiphene Citrate
      2. Letrozole
      3. Serophene
      4. Hormone Treatment
      5. Gonadotrophins
      6. Aromatase Inhibitors
      7. Estrogen Receptor Modulators
      8. Dopamine Agonists
      9. Metformin Hydrochloride
      10. Others
    3. Global Fertility Drug And Surgery Market, By Procedures, 2021 - 2031 (USD Million)
      1. Hysteroscopy
      2. Laparoscopy and Robotic Laparoscopy
      3. Laparotomy/Open Surgery
      4. Egg Retrieval
      5. Varicocelectomy
      6. Vasectomy Reversal
      7. Sperm Retrieval
    4. Global Fertility Drug And Surgery Market, By End User, 2021 - 2031 (USD Million)
      1. Fertility Clinics
      2. Hospitals
      3. Clinical Research Institutes
      4. Others
    5. Global Fertility Drug And Surgery Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
      5. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
  6. Competitive Landscape
    1. Company Profiles
      1. Merck & Co., Inc
      2. Ferring Pharmaceuticals
      3. EMD Serono (Merck KGaA)
      4. Genea Limited
      5. Vitrolife AB
      6. Cook Medical
      7. Irvine Scientific
      8. CooperSurgical, Inc
      9. Progyny, Inc
      10. Thermo Fisher Scientific Inc
  7. Analyst Views
  8. Future Outlook of the Market